CCDC 767715: Experimental Crystal Structure Determination
Scott C. Mayer, J. Steven Jacobsen, Margaret M. Zaleska, Thomas A. Comery(Princeton University), Kevin Woller, Magid Abou‐Gharbia, Derek C. Cole, David Riddell(Eli Lilly (United States)), Ronald L. Magolda(Wilmington University), John W. Ellingboe(Pearl River Community College), J. Zeldis, William H. Moore(New York University), George Diamantidis, Raquel Galante, Joseph R. Stock, Eric J. Wagner(University of Rochester Medical Center), Madelene Antane, Bertrand F. Harrison, Yun Hang Hu(Michigan Technological University), Mikhail Chlenov, June Sonnenberg‐Reines, Kai Fan(Taiyuan University of Science and Technology), Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter H. Reinhart(University of Massachusetts Amherst), Uttam Jain, Minsheng Zhang, Molly Hoke, Christopher R. Gonzales, Kenneth A. M. Kremer, Anthony F. Kreft, Shaiu-Ching Sun, Donna M. Huryn, Dennis Kubrak, ZhengXu, Mei Jin, Lin Ma, Peimin Lu, A. L. Porte, M.N. Pangalos, Suzan Aschmies(Princeton University), Lauren Β. Resnick, Hua Zhou, Ting Wang, Aram Oganesian(Plex Pharmaceuticals (United States)), D.M. Ho, R. Martone
Cited by 0
Related Papers
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
|Journal of Biological Chemistry|1998|3k
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family
|Journal of Biological Chemistry|1999|488
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445